Analytical methodology for developing nanomaterials designed for magnetically-guided delivery of platinum anticancer drugs.


Journal

Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R

Informations de publication

Date de publication:
01 Jun 2022
Historique:
received: 24 01 2022
revised: 05 03 2022
accepted: 07 03 2022
pubmed: 15 3 2022
medline: 8 4 2022
entrez: 14 3 2022
Statut: ppublish

Résumé

Metallodrug delivery using magnetic nanomaterials is emerging as a tool for the treatment of cancer because of its potential of enhanced and controlled delivery to a specific site within the body, reduced side effects, and protection of drugs from the extracellular environment. In this brief review, we discuss recent progress in the development of iron oxide nanoparticles loaded with platinum anticancer drugs due to applying modern analytical techniques. Such techniques may vary depending on what step of manufacture and assessment of magnetic nanocarriers is in question, i.e., drug loading, payload stability, magnetic properties, drug release or the efficiency against different cancer cell lines. While focusing on a wider implementation of advanced analytical methodologies, we also critically contemplate how they help create more potent magnetic nanoformulations, resolve the current challenges with the use of magnetic nanomaterials in smart metallodrug delivery and thus accelerate their translation to human treatments.

Identifiants

pubmed: 35287017
pii: S0039-9140(22)00167-9
doi: 10.1016/j.talanta.2022.123371
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Drug Carriers 0
Magnetite Nanoparticles 0
Platinum 49DFR088MY

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

123371

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Andrei R Timerbaev (AR)

Vernadsky Institute of Geochemistry and Analytical Chemistry, Kosygin St. 19, 119991, Moscow, Russian Federation. Electronic address: andrei.timerbaev@univie.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH